Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

A new scoping review examines the impact of respiratory bacteria on the severity of respiratory syncytial virus (RSV) ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their use.

Merck, the giant pharmaceutical company with multiple facilities in eastern Pennsylvania and New Jersey, isn’t too enthused ...

According to wastewater data aggregated by the Centers for Disease Control and Prevention, not only was there less Covid ...

As health officials report a surge of winter viruses, health experts are warning that heart disease symptoms can sometimes ...

• Respiratory syncytial virus (RSV) infections are above the alert level. • Seasonal influenza (flu) infections are well ...

S-337395 is an investigational oral antiviral candidate for RSV infection that inhibits the activity of the L protein, which is essential for virus replication. 1,2 Furthermore, this drug has received ...

“Right now, flu is the driver,” Demetre Daskalakis, who directs the Centers for Disease Control and Prevention’s response to ...

To learn more about the recent bird flu outbreaks, we spoke with Asha Shah, MD, director of infectious diseases and ...

The FDA approved a wide range of therapies in 2024, including many new molecular entities and biological products.